Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India

Keyphrases

• Visceral Leishmaniasis 100%
• India 100%
• Laboratory Confirmation 100%
• Resistant Cases 100%
• Miltefosine 100%
• IC50 27%
• Leishmania Donovani 18%
• Single nucleotide Polymorphism 18%
• Amphotericin B 18%
• Laboratory Confirmed Cases 18%
• Bihar 18%
• Sb(III) 18%
• Miltefosine Resistance 18%
• Endemic State 18%
• Gene Expression 9%
• Antileishmanial 9%
• IC50 Value 9%
• Non-endemic 9%
• Molecular Markers 9%
• Broad-spectrum Antibiotics 9%
• Somatic mutation Analysis 9%
• Control Measures 9%
• Genetic Analysis 9%
• In Vitro Resistance 9%
• Drug Susceptibility 9%
• Antipyretic 9%
• Eastern India 9%
• Blood Buffy Coat 9%
• Drug Susceptibility Testing 9%
• Jharkhand State 9%

Biochemistry, Genetics and Molecular Biology

• IC50 100%
• Single-Nucleotide Polymorphism 50%
• Drug Sensitivity 50%
• Genetics 25%
• Gene Expression 25%
• Gene Mutation 25%
• Genetic Marker 25%
• Leishmania donovani 25%

Immunology and Microbiology

• Visceral Leishmaniasis 100%
• IC50 36%
• Single Nucleotide Polymorphism 18%
• Drug Sensitivity 18%
• Gene Expression 9%
• Gene Mutation 9%
• Genetic Marker 9%
• Leishmania donovani 9%
• Blood Buffy Coat 9%
• In Vitro 9%